An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectivel...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-08-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC4526370?pdf=render |
_version_ | 1818008404847755264 |
---|---|
author | Claire A Schreiber Toshie Sakuma Yoshihiro Izumiya Sara J Holditch Raymond D Hickey Robert K Bressin Upamanyu Basu Kazunori Koide Aravind Asokan Yasuhiro Ikeda |
author_facet | Claire A Schreiber Toshie Sakuma Yoshihiro Izumiya Sara J Holditch Raymond D Hickey Robert K Bressin Upamanyu Basu Kazunori Koide Aravind Asokan Yasuhiro Ikeda |
author_sort | Claire A Schreiber |
collection | DOAJ |
description | Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors. |
first_indexed | 2024-04-14T05:29:06Z |
format | Article |
id | doaj.art-5782021d39314041814496d41ad5a7ef |
institution | Directory Open Access Journal |
issn | 1553-7366 1553-7374 |
language | English |
last_indexed | 2024-04-14T05:29:06Z |
publishDate | 2015-08-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS Pathogens |
spelling | doaj.art-5782021d39314041814496d41ad5a7ef2022-12-22T02:09:53ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742015-08-01118e100508210.1371/journal.ppat.1005082An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.Claire A SchreiberToshie SakumaYoshihiro IzumiyaSara J HolditchRaymond D HickeyRobert K BressinUpamanyu BasuKazunori KoideAravind AsokanYasuhiro IkedaAdeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors.http://europepmc.org/articles/PMC4526370?pdf=render |
spellingShingle | Claire A Schreiber Toshie Sakuma Yoshihiro Izumiya Sara J Holditch Raymond D Hickey Robert K Bressin Upamanyu Basu Kazunori Koide Aravind Asokan Yasuhiro Ikeda An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. PLoS Pathogens |
title | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. |
title_full | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. |
title_fullStr | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. |
title_full_unstemmed | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. |
title_short | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. |
title_sort | sirna screen identifies the u2 snrnp spliceosome as a host restriction factor for recombinant adeno associated viruses |
url | http://europepmc.org/articles/PMC4526370?pdf=render |
work_keys_str_mv | AT claireaschreiber ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT toshiesakuma ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT yoshihiroizumiya ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT sarajholditch ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT raymonddhickey ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT robertkbressin ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT upamanyubasu ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT kazunorikoide ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT aravindasokan ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT yasuhiroikeda ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT claireaschreiber sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT toshiesakuma sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT yoshihiroizumiya sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT sarajholditch sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT raymonddhickey sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT robertkbressin sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT upamanyubasu sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT kazunorikoide sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT aravindasokan sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT yasuhiroikeda sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses |